Fonar EBITDA Margin 2010-2024 | FONR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fonar (FONR) over the last 10 years. The current EBITDA margin for Fonar as of September 30, 2024 is .
| Fonar EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.10B | $0.02B | 22.55% |
| 2024-06-30 | $0.10B | $0.03B | 24.27% |
| 2024-03-31 | $0.10B | $0.03B | 26.21% |
| 2023-12-31 | $0.10B | $0.03B | 26.47% |
| 2023-09-30 | $0.10B | $0.03B | 26.73% |
| 2023-06-30 | $0.10B | $0.02B | 24.49% |
| 2023-03-31 | $0.10B | $0.03B | 25.77% |
| 2022-12-31 | $0.10B | $0.03B | 27.84% |
| 2022-09-30 | $0.10B | $0.03B | 29.90% |
| 2022-06-30 | $0.10B | $0.03B | 31.63% |
| 2022-03-31 | $0.10B | $0.03B | 30.61% |
| 2021-12-31 | $0.10B | $0.03B | 28.13% |
| 2021-09-30 | $0.09B | $0.03B | 26.88% |
| 2021-06-30 | $0.09B | $0.02B | 25.56% |
| 2021-03-31 | $0.09B | $0.02B | 20.93% |
| 2020-12-31 | $0.09B | $0.02B | 20.00% |
| 2020-09-30 | $0.09B | $0.02B | 20.00% |
| 2020-06-30 | $0.09B | $0.02B | 20.93% |
| 2020-03-31 | $0.09B | $0.02B | 26.44% |
| 2019-12-31 | $0.09B | $0.03B | 30.68% |
| 2019-09-30 | $0.09B | $0.03B | 30.68% |
| 2019-06-30 | $0.09B | $0.03B | 29.89% |
| 2019-03-31 | $0.09B | $0.03B | 31.40% |
| 2018-12-31 | $0.08B | $0.02B | 28.57% |
| 2018-09-30 | $0.08B | $0.02B | 28.92% |
| 2018-06-30 | $0.08B | $0.02B | 29.63% |
| 2018-03-31 | $0.08B | $0.02B | 28.40% |
| 2017-12-31 | $0.08B | $0.03B | 31.25% |
| 2017-09-30 | $0.08B | $0.02B | 29.49% |
| 2017-06-30 | $0.08B | $0.02B | 29.49% |
| 2017-03-31 | $0.08B | $0.02B | 27.63% |
| 2016-12-31 | $0.08B | $0.02B | 25.33% |
| 2016-09-30 | $0.08B | $0.02B | 25.33% |
| 2016-06-30 | $0.07B | $0.02B | 22.97% |
| 2016-03-31 | $0.07B | $0.02B | 25.00% |
| 2015-12-31 | $0.07B | $0.02B | 24.29% |
| 2015-09-30 | $0.07B | $0.02B | 23.19% |
| 2015-06-30 | $0.07B | $0.02B | 23.19% |
| 2015-03-31 | $0.07B | $0.02B | 23.19% |
| 2014-12-31 | $0.07B | $0.02B | 21.74% |
| 2014-09-30 | $0.07B | $0.02B | 21.43% |
| 2014-06-30 | $0.07B | $0.02B | 23.19% |
| 2014-03-31 | $0.07B | $0.02B | 21.43% |
| 2013-12-31 | $0.07B | $0.01B | 21.54% |
| 2013-09-30 | $0.06B | $0.01B | 21.05% |
| 2013-06-30 | $0.05B | $0.01B | 18.00% |
| 2013-03-31 | $0.04B | $0.01B | 20.93% |
| 2012-12-31 | $0.04B | $0.01B | 21.95% |
| 2012-09-30 | $0.04B | $0.01B | 22.50% |
| 2012-06-30 | $0.04B | $0.01B | 22.50% |
| 2012-03-31 | $0.04B | $0.01B | 18.92% |
| 2011-12-31 | $0.04B | $0.01B | 19.44% |
| 2011-09-30 | $0.04B | $0.01B | 20.00% |
| 2011-06-30 | $0.03B | $0.01B | 17.65% |
| 2011-03-31 | $0.04B | $0.01B | 14.29% |
| 2010-12-31 | $0.03B | $0.00B | 8.82% |
| 2010-09-30 | $0.03B | 0 | 0.00% |
| 2010-06-30 | $0.03B | $-0.00B | -6.25% |
| 2010-03-31 | $0.03B | $-0.00B | -6.06% |
| 2009-12-31 | $0.04B | $-0.00B | -2.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.096B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |